Form 8-K NEUROCRINE BIOSCIENCES For: Apr 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Neurocrine Biosciences (NBIX) Tops Q1 EPS by 29c
April 30, 2015 9:41 AM EDTNeurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of ($0.01), $0.29 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
... More


